KLH-2109: Clinical Trials

7 trials of KLH-2109, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 active not recruiting. 4 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 33Completed 2, Active not recruiting 1

Follow KLH-2109: new trials by email Literature Review of KLH-2109 trials Research Report on KLH-2109

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study of KLH-2109 in Patients With Endometriosis
KLH-2109, Leuprorelin acetate - Endometriosis
Phase 3Active not recruitingKissei Pharmaceutical Co., Ltd.2882025-06-092026-03-02
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain
KLH-2109, Placebo - Uterine Fibroids (MeSH Heading: Leiomyoma)
Phase 3CompletedKissei Pharmaceutical Co., Ltd.892022-10-112025-11-25
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia
KLH-2109, Leuprorelin - Uterine Fibroids (MeSH Heading: Leiomyoma)
Phase 3CompletedKissei Pharmaceutical Co., Ltd.2872022-10-112025-03-14
Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis
KLH-2109, Placebo, Leuprorelin acetate - Endometriosis
Phase 2CompletedKissei Pharmaceutical Co., Ltd.2016-05-092019-06-04
A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)
KLH-2109 - Endometriosis
Phase 2CompletedKissei Pharmaceutical Co., Ltd.202013-10-30
A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)
KLH-2109, placebo - Endometriosis
Phase 2CompletedKissei Pharmaceutical Co., Ltd.1002014-05-30
A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis
KLH-2109 - Endometriosis
Phase 2CompletedKissei Pharmaceutical Co., Ltd.202014-05-30

Conditions studied

Endometriosis (5)  ·  Leiomyoma (2)

Sponsors

Kissei Pharmaceutical Co., Ltd. (7)

Countries

Japan (7)

Top investigators

Yoshitaka Shimizu (3)  ·  Katsumi Hontani (1)  ·  Tatsuro Takei (1)

Results publications

PMID 42406777